Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 352 results for "drl"

Dr Reddy's recalls Rivastigmine Tartrate capsules from US market

DRL recalls 1.5 mg Rivastigmine Tartrate capsules from US

HYDERABAD: Dr Reddy's Laboratories (DRL) has initiated voluntary recall of Rivastigmine Tartrate Capsules of 1.5 mg strength from the USA market, following 'Failed Dissolution Specifications'. A total of 60 bottles of 2952 units are recalled on the direction ... Economic Times, 1 week ago
Dr Reddy's shares hit new 52 First, 3 weeks ago

14 images for drl

Internet Retailing, 6 days ago
India Infoline, 1 week ago
Money Control, 1 week ago
Financial Express, 1 week ago
Sify, 2 weeks ago, 3 weeks ago
Primped, 3 weeks ago
DNA India, 3 weeks ago
India Today, 3 weeks ago
Sify, 3 weeks ago

Dr. Reddy's Labs in focus after launching Pramipexole dihydrochloride tablets

Dr. Reddy's Laboratories (DRL) announced yesterday, 12 August 2015 that the company has launched Pramipexole dihydrochloride extended-release tablets 0.375 mg, 0.75 mg, 1.5 mg, 3 mg and 4.5 mg, a therapeutic equivalent generic version of Mirapex ER ...
 Business Standard2 weeks ago Dr Reddy's Labs floats new venture business  Times of India3 weeks ago Dr Reddy's Labs in focus after launching generic dementia treatment tablets in US  Business Standard1 month ago Dr Reddy's Labs gains after launching generic dementia treatment tablets in US  Capital Market1 month ago

DRL posts consolidated revenues of Rs 37.6 billion, showing seven per cent growth YoY

Gross profit margin were at 61.1 per cent Dr Reddy's Laboratories (DRL) announced its consolidated financial results for the quarter ended June 30, 2015 under International Financial Reporting Standards (IFRS). . The consolidated revenues were at ...
 Financial Express3 weeks ago DRL net rises 14% on better sales in North America  Financial Express4 weeks ago DRL's net up 14% at Rs 626 crore; Russia a drag  Business Standard4 weeks ago
New Indian Express

Top Pharma news of the day

Dr Reddy's Laboratories (DRL), the nation's second largest drug maker by revenue, is in talks with some European and Japanese giants to form licensing or marketing agreements to sell their medicines in the Rs 90,000 crore domestic market, a strategy aimed ...
 India Infoline2 weeks ago Dr Reddy's crossed Rs.4000 mark on BSE with 86% income from exports, new launches  PharmaBiz3 weeks ago Dr Reddy's Q1 Net Up 14 Percentage at Rs 626 cr  New Indian Express4 weeks ago Dr Reddy's Labs net surges by 14% in Q1 to Rs. 626 cr  PharmaBiz4 weeks ago

Dr Reddy's Labs joins hands with US-based Purdue University for better medical research

The US-based Purdue University has signed a Memorandum of Understanding (MoU) with Dr Reddy's Laboratories Limited (DRL) to strengthen pharmaceutical research and development. According to a statement issued by the University, the intent of the MoU ...
 Yourstory.in3 weeks ago Dr Reddy's signs MoU with Purdue University for drug research  Hindu Business Line4 weeks ago Dr Reddy's ink pact with Purdue varsity for drug research  The Financial Chronicle4 weeks ago DRL ink pact with Purdue varsity for drug research  Financial Express4 weeks ago

Sensex, Nifty flat amid lackluster trades; DRL, Rolta up sharply

With stocks swinging between losses amid alternate bouts of buying and selling this morning, the benchmark indices Sensex and the Nifty continue to hover around their previous closing levels after opening on a cautious note. Due to a lack of prominent ...
 Sify3 weeks ago Sensex down 69 points; Coal India, DRL trade higher  Sify1 month ago

DRL launches generic drug for Parkinson's treatment in US

he US market. It has launched the tablets in the strengths of 0.375 mg, 0.75 mg, 1.5 mg, 3 mg and 4.5 mg in the US market following approval from the US Food & Drug Administration (USFDA), Dr Reddy's Laboratories said in a statement. The company's product is ...
 Business Standard2 weeks ago Drug to Treat Parkinson's Disease Launched in the US Market by Dr Reddy's Laboratories  MedIndia2 weeks ago

Sensex ends 75 higher, Nifty at 8589; LT, DRL gainers

LT, Dr Reddy's Labs, Lupin, Tata Motors and SBI were leaders while ITC, Coal India, Vedanta, Reliance and Wipro were losers in the Sensex.
 Money Control3 weeks ago
Financial Express

DRL recalls some drugs

Pharma major Dr. Reddy's Laboratories has voluntarily started recalling some of its drugs used to treat seizure and hypertension from the US market. According to the enforcement report of the USFDA, for the week ended June 24, the company last ...
 The Hindu1 month ago DRL Recalls Select Drugs from US Mkt  New Indian Express1 month ago DRL recalls anti-seizure drugs from US market  Press Trust of India1 month ago DRL recalls anti-seizure, hypertension drugs from US market  The Financial Chronicle1 month ago
Ani News

Police neutralize explosives recovered from terrorists

GURDASPUR: Police, with the help of Army personnel, on Sunday disposed of the single-shot disposable rocket launcher (DRL) recovered after the three terrorists who attacked Dinanagar police station last Monday were shot dead. The DRL was disposed of ...
 Times of India3 weeks ago Punjab Police took army's help to defuse Gurdaspur terrorists' rocket launcher  Ani News3 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less